back to vol. 15, b. 1, 2009

Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312-773X (Online)
Issue: Volume 15, book 1, 2009
Subject Collection: Medicine
Page: 78 - 81
DOI: 10.5272/jimab.1512009_78
Online date: Sept. 11, 2009,

Lyudmila G. Vladimirova-Kitova,
Clinic of Cardiology, Medical University-Plovdiv, Bulgaria;
SUMMARY: Background: Severe hypercholesterolemia and family history of early vascular diseases are important determinants of the development of the endothelium dependent vasodilation in familial hypercholesterolemia. Mutations of the LDL-R-gene (low-density lipoprotein receptor gene) are characterized by a high genetic heterogenicity.  Nearly 80% of the population specific heterogenicity are due to point mutations along the LDL-R gene. The different expression of the defect gene in LDL-R mutation carriers as well as the presence of elevated LDL levels in non-mutation carriers makes diagnosis difficult. So far, there is no optimal diagnostic algorithm in familial hypercholesterolemia. Objective To study the endothelium-dependent vasodilation (flow-mediated vasodilation) in carriers and noncarriers of LDL-R defective gene and utilize them to screen for defects in the LDL receptor (spot mutations and polymorphisms) in severe hypercholesterolemia (HC) in molecular biological analysis. Study was conducted in patients with diagnosed and presumed familial hypercholesterolemia according to Simon-Broome criteria. Мaterials and methods: 464 first relatives of families with familial hypercholesterolemia were tested, of them 120 meet  Simon-Broome inclusion criteria. Total cholesterol, triglycerides, cholesterol of high density lipoproteins, cholesterol of low density lipoproteins  are determined, using the enzyme- colorimetric method. Molecular analysis included: DNA isolation, amplification of a target DNA fragment by polymerase chain reaction, Single Strand Conformation Polymorphysm (SSCP)  and direct DNA sequencing. The  Hewlett Packard SONOS 5500  with a 7.5 MHz triplex transducer and the MedicaSoft.IMT lab software packet were used to determine the flow-mediated vasodilation.  Results:  According to the presence or absence of genetic mutations, patients were assigned into two groups - carriers  of LDL-R  gene point mutations - 22  (18.33%) patients - of them 16 (13.33%) were carriers of an unknown mutation (not registered in the available data bases—1073G>A) and non-carriers - 98 patients – 81.67%.  All 18 exons of the  LDL-R  gene were tested. Median age of non-carriers is  43.41±0.43 years, that of carriers –45.40±0.27 years (р<0.001). There is no statistically significant difference in the patients’ distribution according to sex (x2=0.06; р>0.05). There is not statistical significant difference on all biomarkers of the atherogenic risk between two group (p>0.05), as for flow-mediated vasodilation (p>0.05). Conclusion: Endothelium-dependent vasodilation (flow-mediated vasodilation) are not an indicator of the presence of point mutations and polymorphisms of the LDL-R gene.
Key words:hypercholesterolemia, low-density lipoprotein, LDL-R, flow-mediated vasodilation, apolipo­proteins.

Page: 78-81; FULL TEXT PDF (126 KB)

back to Online Journal